The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced considerable risk . Investors are now assessing the effect of rival medi